Skip to content
10-K

Annual Report

Infinity Pharmaceuticals, Inc.

0001113148-23-000003

← back to feed
Filed
Mar 28, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 21, 2023 89.42M sh
Shares Diluted FY 2022 · Dec 31, 2022 89.25M sh
Shares Diluted FY 2022 · Dec 31, 2021 85.6M sh
Capex FY 2022 · Dec 31, 2022 $17K
Capex FY 2022 · Dec 31, 2021 $11K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$42.43M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$40.62M
Cash And Equivalents FY 2022 · Dec 31, 2022 $38.31M
Cash And Equivalents FY 2022 · Dec 31, 2021 $80.73M
Stockholders Equity FY 2022 · Dec 31, 2022 −$19.05M
Stockholders Equity FY 2022 · Dec 31, 2021 $21.57M
Stockholders Equity FY 2022 · Dec 31, 2020 −$22.99M
Current Liabilities FY 2022 · Dec 31, 2022 $13.63M
Current Liabilities FY 2022 · Dec 31, 2021 $13.3M
Total Liabilities FY 2022 · Dec 31, 2022 $61.2M
Total Liabilities FY 2022 · Dec 31, 2021 $63.21M
Current Assets FY 2022 · Dec 31, 2022 $40.3M
Current Assets FY 2022 · Dec 31, 2021 $82.27M
Total Assets FY 2022 · Dec 31, 2022 $42.15M
Total Assets FY 2022 · Dec 31, 2021 $84.79M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.50
Eps Diluted FY 2022 · Dec 31, 2021 −$0.53
Eps Basic FY 2022 · Dec 31, 2022 −$0.50
Eps Basic FY 2022 · Dec 31, 2021 −$0.53
Sga Expense FY 2022 · Dec 31, 2022 $13.46M
Sga Expense FY 2022 · Dec 31, 2021 $14.17M
Rd Expense FY 2022 · Dec 31, 2022 $32.41M
Rd Expense FY 2022 · Dec 31, 2021 $31.65M
Net Income FY 2022 · Dec 31, 2022 −$44.37M
Net Income FY 2022 · Dec 31, 2021 −$45.26M
Operating Income FY 2022 · Dec 31, 2022 −$44.84M
Operating Income FY 2022 · Dec 31, 2021 −$45.08M
Revenue FY 2022 · Dec 31, 2022 $2.59M
Revenue FY 2022 · Dec 31, 2021 $1.86M